Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation

摘要

The disclosure is directed to methods for treating inflammatory conditions and cancers that have misregulated NF-κB. In some embodiments, the disclosure is directed to methods for treating inflammatory conditions, inflammatory states associated with treating HIV and AIDS infections, and cancers that include administering strontium ranelate to a subject diagnosed with or at risk of inflammatory conditions, inflammatory states, and cancers, respectively.

主权项

1. A method of treating an inflammatory condition comprising administering strontium ranelate to a subject at risk of, exhibiting symptoms of, or diagnosed with the inflammatory condition.